M Veronese

1.3k citations
21 papers · 1.2k indexed · h-index 14
Topics
Pharmacogenetics and Drug Metabolism (10 papers)Drug Transport and Resistance Mechanisms (4 papers)Carcinogens and Genotoxicity Assessment (3 papers)

In The Last Decade

M Veronese

20 papers receiving 1.1k citations

Peers

M Veronese
Comparison fields: 5 of 83
  • Pharmacology 788
  • Molecular Biology 440
  • Oncology 379
  • Cancer Research 189
  • Pharmacology 116
Replace Masayuki Komori with:
Masayuki Komori Japan
Toshifumi Aoyama United States
G. Gordon Gibson United Kingdom
Deborah Dunbar United States
Mitsukazu Kitada Japan
D P Lapenson United States
DS Davies United Kingdom
T. Wolff Germany
L R Pohl United States
F. Peter Guengerich United States
M Veronese relative to Masayuki Komori Japan Masayuki Komori's profile →
Citations per field
00.5×1.5×
Masayuki Komori · 1×
Citations per year

Countries citing papers authored by M Veronese

Since Specialization
Citations

This map shows the geographic impact of M Veronese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Veronese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Veronese more than expected).

Fields of papers citing papers by M Veronese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Veronese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Veronese. The network helps show where M Veronese may publish in the future.

Co-authorship network of co-authors of M Veronese

This figure shows the co-authorship network connecting the top 25 collaborators of M Veronese. A scholar is included among the top collaborators of M Veronese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Veronese. M Veronese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 19
3 62
4 49
5 13
6 293
7 76
8 60
9 118
10 73
11
Co-regulation of phenytoin and tolbutamide metabolism in humans.
38
12 9
13 12
14 36
15
Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.
257
16
Experimental studies in vitro and in vivo on the mutagenicity of flavoxate.
2
17 19
18
Mutagenicity studies on denzimol, a new anticonvulsant drug.
0
19
[Mutagenesis of efloxate tested in vitro and in vivo].
1
20
Urinary excretion in the rat of nifurpipone (NP) and of nitrofurantoin (NTF) administered by different routes.
4

About M Veronese

M Veronese is a scholar working on Pharmacology, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Pharmacology (788 citations), Biochemistry (106 citations) and Oncology (379 citations). M Veronese has collaborated with scholars based in Australia, United States and Italy. Frequent co-authors include Michael E. McManus, John O. Miners, Linda C. Quattrochi, Donald Birkett, Wendy Burgess, Wichittra Tassaneeyakul, Anthony C. Huggett, R H Tukey, Robert H. Tukey and Lloyd Sansom. Their work appears in journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026